Kwality Pharmaceuticals Ltd

Kwality Pharma Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Kwality Pharmaceuticals Ltd

₹ 502 -0.98%
25 Apr 4:01 p.m.
kwalitypharma.com BSE: 539997
About

Incorporated in 1983, Kwality Pharma is in the business of manufacturing & trading in Pharmaceuticals & allied products[1]

Key Points

Business Overview:[1][2]
KPL is in an ANVISA and EU GMP certified manufacturer of all pharma products including complex molecules across all dosage forms including niche Biologics. It has a portfolio of 3000+ formulations across 25+ therapeutic areas with categories including generics, cephalosporin, beta-lactam, oncology & biologics. It manufactures and deals in drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations

Website BSE
  • Market Cap ₹ 521 Cr.
  • Current Price ₹ 502
  • High / Low ₹ 545 / 248
  • Stock P/E 18.5
  • Book Value ₹ 204
  • Dividend Yield 0.00 %
  • ROCE 18.6 %
  • ROE 16.5 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 48.1% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 45.5%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Debtor days have increased from 69.8 to 104 days.
  • Working capital days have increased from 115 days to 209 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
120.21 183.74 88.19 64.05 70.22 55.81 56.20 68.80 67.45 69.65 78.10
72.70 100.35 63.66 47.82 52.22 40.26 41.10 57.31 53.68 54.42 61.42
Operating Profit 47.51 83.39 24.53 16.23 18.00 15.55 15.10 11.49 13.77 15.23 16.68
OPM % 39.52% 45.38% 27.81% 25.34% 25.63% 27.86% 26.87% 16.70% 20.42% 21.87% 21.36%
0.96 0.12 0.84 1.60 0.38 1.13 0.35 -15.07 0.40 0.23 0.62
Interest 0.68 0.71 0.50 1.03 1.22 1.18 1.95 1.67 2.19 2.41 2.73
Depreciation 2.07 2.66 3.20 2.76 3.14 3.84 3.55 4.43 4.79 4.88 4.82
Profit before tax 45.72 80.14 21.67 14.04 14.02 11.66 9.95 -9.68 7.19 8.17 9.75
Tax % 24.93% 25.61% 26.77% 25.28% 24.96% 19.47% 28.14% 23.55% 24.90% 23.87% 21.23%
34.31 59.62 15.86 10.49 10.53 9.39 7.14 -7.40 5.40 6.22 7.68
EPS in Rs 33.09 57.48 15.29 10.12 10.16 9.08 6.84 -7.11 5.22 6.01 7.41
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
60 52 74 98 137 166 139 262 456 251 284
56 49 69 89 126 150 125 233 285 190 227
Operating Profit 4 3 5 9 12 16 14 29 172 61 57
OPM % 6% 6% 7% 9% 8% 9% 10% 11% 38% 24% 20%
0 0 0 1 1 1 4 2 4 -14 -14
Interest 1 1 1 2 2 2 3 3 3 7 9
Depreciation 1 1 2 3 3 3 4 6 11 15 19
Profit before tax 2 1 2 6 7 11 11 21 162 26 15
Tax % 47% 41% 48% 42% 39% 31% 25% 30% 26% 25%
1 1 1 3 4 8 8 15 120 19 12
EPS in Rs 0.93 0.92 1.55 3.23 4.39 7.28 8.02 14.60 115.64 18.67 11.53
Dividend Payout % 0% 0% 0% 9% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 13%
3 Years: 22%
TTM: 15%
Compounded Profit Growth
10 Years: %
5 Years: 48%
3 Years: 57%
TTM: -25%
Stock Price CAGR
10 Years: %
5 Years: 64%
3 Years: 95%
1 Year: 36%
Return on Equity
10 Years: %
5 Years: 41%
3 Years: 46%
Last Year: 17%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 4 4 5 5 10 10 10 10 10 10 10
Reserves 13 15 17 20 19 27 36 51 171 190 202
6 8 13 19 26 29 35 41 54 90 91
12 10 17 26 40 39 52 64 105 70 52
Total Liabilities 35 37 51 71 96 105 133 166 341 361 355
13 13 13 17 20 29 43 57 92 120 136
CWIP 0 0 0 0 0 0 0 3 12 14 0
Investments 1 1 2 4 5 5 4 5 0 0 0
22 24 37 50 70 71 86 102 237 226 219
Total Assets 35 37 51 71 96 105 133 166 341 361 355

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-1 1 -3 4 -1 14 6 27 61 41
-3 -1 -2 -7 -6 -12 -18 -23 -63 -48
3 1 6 5 5 -2 12 1 6 1
Net Cash Flow -1 1 0 2 -1 -0 0 4 3 -6

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 41 63 89 84 98 84 79 50 55 104
Inventory Days 58 61 67 71 54 34 94 38 97 310
Days Payable 58 40 63 65 80 52 96 58 63 117
Cash Conversion Cycle 42 85 93 90 73 67 77 30 90 297
Working Capital Days 61 81 89 76 74 61 99 47 87 209
ROCE % 9% 13% 19% 19% 22% 18% 26% 98% 19%

Shareholding Pattern

Numbers in percentages

3 Recently
Mar 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
54.13% 54.24% 54.24% 54.43% 54.45% 54.44% 54.44% 54.73% 54.73% 54.76% 54.76% 54.82%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.01% 0.01% 0.01% 0.01% 0.00%
45.87% 45.76% 45.76% 45.57% 45.55% 45.56% 45.54% 45.25% 45.25% 45.22% 45.22% 45.17%
No. of Shareholders 1481683795811,0494,1985,3766,2116,9436,2915,7865,695

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls

  • Aug 2023
    Transcript
    Notes
    PPT
  • May 2022
    Transcript
    Notes
    PPT